miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1. (Q46037039)

18 December 2017

title

miR-137 restoration sensitizes multidrug-resistant MCF-7/ADM cells to anticancer agents by targeting YB-1. (English)

1 reference

18 December 2017

main subject

multiple drug resistance

1 reference

Xiaolan Zhu

1

1 reference

18 December 2017

Yuefeng Li

2

1 reference

18 December 2017

Huiling Shen

3

1 reference

18 December 2017

Hao Li

4

1 reference

18 December 2017

Lulu Long

5

1 reference

18 December 2017

Lulu Hui

6

1 reference

18 December 2017

Wenlin Xu

7

1 reference

18 December 2017

publication date

23 November 2012

1 reference

18 December 2017

Acta Biochimica et Biophysica Sinica

published in

1 reference

18 December 2017

volume

45

1 reference

18 December 2017

issue

2

1 reference

18 December 2017

page(s)

80-86

1 reference

18 December 2017

Targeting multidrug resistance in cancer

cites work

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Search for MDR modulators: design, syntheses and evaluations of N-substituted acridones for interactions with p-glycoprotein and Mg2+.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Multidrug resistance: retrospect and prospects in anti-cancer drug treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Gene regulation by Y-box proteins: coupling control of transcription and translation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Y-box factor YB-1 predicts drug resistance and patient outcome in breast cancer independent of clinically relevant tumor biologic factors HER2, uPA and PAI-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Nuclear localization and increased levels of transcription factor YB-1 in primary human breast cancers are associated with intrinsic MDR1 gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

MicroRNAs and chromosomal abnormalities in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

miR-21-mediated tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

miR-126 enhances the sensitivity of non-small cell lung cancer cells to anticancer agents by targeting vascular endothelial growth factor A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Involvement of microRNA-451 in resistance of the MCF-7 breast cancer cells to chemotherapeutic drug doxorubicin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

HPMA copolymer-bound doxorubicin induces apoptosis in human ovarian carcinoma cells by a Fas-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Epigenetics, microRNAs, and carcinogenesis: functional role of microRNA-137 in uveal melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

miR-137 targets Cdc42 expression, induces cell cycle G1 arrest and inhibits invasion in colorectal cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

MicroRNAs in ovarian cancer biology and therapy resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Alterations of microRNAs and their targets are associated with acquired resistance of MCF-7 breast cancer cells to cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

MicroRNA-328 negatively regulates the expression of breast cancer resistance protein (BCRP/ABCG2) in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

MicroRNA-137 promoter methylation in oral rinses from patients with squamous cell carcinoma of the head and neck is associated with gender and body mass index

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

MiR-137 targets estrogen-related receptor alpha and impairs the proliferative and migratory capacity of breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FABBS%2FGMS099

21 January 2018

Identifiers

DOI

10.1093/ABBS/GMS099

1 reference

18 December 2017

PubMed ID

23178914

1 reference

18 December 2017